NASDAQ:BCPC • US0576652004
The current stock price of BCPC is 171.78 USD. Today BCPC is down by -0.5%. In the past month the price decreased by -0.29%. In the past year, price increased by 2.94%.
ChartMill assigns a technical rating of 6 / 10 to BCPC. When comparing the yearly performance of all stocks, BCPC turns out to be only a medium performer in the overall market: it outperformed 57.98% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to BCPC. BCPC has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
On February 20, 2026 BCPC reported an EPS of 1.31 and a revenue of 263.62M. The company missed EPS expectations (-0.05% surprise) and missed revenue expectations (-0.44% surprise).
9 analysts have analysed BCPC and the average price target is 200.69 USD. This implies a price increase of 16.83% is expected in the next year compared to the current price of 171.78.
For the next year, analysts expect an EPS growth of 11.9% and a revenue growth 6.65% for BCPC
Over the last trailing twelve months BCPC reported a non-GAAP Earnings per Share(EPS) of 5.15. The EPS increased by 17.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.93% | ||
| ROA | 9.18% | ||
| ROE | 12.31% | ||
| Debt/Equity | 0.13 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SHW | SHERWIN-WILLIAMS CO/THE | 27.52 | 82.606B | ||
| ECL | ECOLAB INC | 32.71 | 79.476B | ||
| PPG | PPG INDUSTRIES INC | 13.08 | 24.193B | ||
| ALB | ALBEMARLE CORP | 22.15 | 19.984B | ||
| DD | DUPONT DE NEMOURS INC | 20.64 | 18.955B | ||
| IFF | INTL FLAVORS & FRAGRANCES | 16.26 | 18.691B | ||
| RPM | RPM INTERNATIONAL INC | 16.93 | 13.146B | ||
| SOLS | SOLSTICE ADV MATERIALS INC | 27.26 | 11.727B | ||
| EMN | EASTMAN CHEMICAL CO | 11.74 | 7.941B | ||
| ESI | ELEMENT SOLUTIONS INC | 18.45 | 7.86B | ||
| AXTA | AXALTA COATING SYSTEMS LTD | 10.81 | 6.25B | ||
| NEU | NEWMARKET CORP | N/A | 5.836B | ||
| CE | CELANESE CORP | 9.12 | 5.634B |
View all stocks in the Specialty Chemicals Industry | View all stocks in the Materials Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Balchem Corp. provides marketing of specialty performance ingredients and products. The company is headquartered in Montvale, New Jersey and currently employs 1,352 full-time employees. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
IPO: 1986-06-03
BALCHEM CORP
5 Paragon Drive
Montvale NEW JERSEY 10958 US
CEO: Theodore L. Harris
Employees: 1379
Phone: 18453265600
Balchem Corp. provides marketing of specialty performance ingredients and products. The company is headquartered in Montvale, New Jersey and currently employs 1,352 full-time employees. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
The current stock price of BCPC is 171.78 USD. The price decreased by -0.5% in the last trading session.
BALCHEM CORP (BCPC) has a dividend yield of 0.55%. The yearly dividend amount is currently 0.88.
BCPC has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
BCPC stock is listed on the Nasdaq exchange.
You can find the ownership structure of BALCHEM CORP (BCPC) on the Ownership tab.
The outstanding short interest for BALCHEM CORP (BCPC) is 0.87% of its float.